கூட்டமைப்பு கூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கூட்டமைப்பு கூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கூட்டமைப்பு கூ Today - Breaking & Trending Today

KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership

KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Columbia University , Nickolayv Kukekov , Anthonyj Giovinazzo , Jacki Jenuth , Ontario Brain Institute , Prnewswire Kalgene Pharmaceuticals Inc , Consortium Qu , Weston Brain Institute , National Research Council , College Of Physicians Surgeons , Mcgill University , Kalgene Pharmaceuticals Inc , Executive Chairman , Gene Pharmaceuticals , Central Nervous System , Cynapsus Therapeutics , Toxic Oligomers , Wall Street , Lumira Ventures , Brain Canada , Kalgene Pharmaceuticals , Toxic Oligomer , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,

Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types TH1902 anti-tumor post-treatment effect persists longer than with docetaxel alone

Article content
MONTREAL, April 10, 2021 (GLOBE NEWSWIRE) Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that new
in vivo preclinical data were presented at the 2021 Annual Meeting of the American Association for Cancer Research (AACR). These data demonstrated sustained tumor regression, better anti-tumor activity and tolerability with TH1902 compared to docetaxel alone in all cancer types studied, namely melanoma, pancreatic, ovarian, endometrial, colorectal and triple-negative breast cancers. The anti-tumor effect of TH1902 persisted longer post-treatment than with docetaxel alone. TH1902 is the Company’s lead investigational peptide-drug conjugate (PDC) derived from its SORT1+ Technology™. ....

United States , Leah Gibson , Christian Marsolais , Borhane Annabi , Denis Boucher , Canadian Cancer Society , Consortium Qu , Theratechnologies Inc , Corporate Affairs , American Association , Cancer Research , Senior Vice President , Chief Medical Officer , ஒன்றுபட்டது மாநிலங்களில் , லியா கிப்சன் , டெனிஸ் பவுச்சர் , கனடியன் புற்றுநோய் சமூகம் , கூட்டமைப்பு கூ , பெருநிறுவன வாழ்க்கைத்தொழில்கள் , அமெரிக்கன் சங்கம் , புற்றுநோய் ஆராய்ச்சி , மூத்தவர் துணை ப்ரெஸிடெஂட் , தலைமை மருத்துவ அதிகாரி ,

Theratechnologies (THTX) Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors

Theratechnologies (THTX) Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Satish Shah , Tina Khair , Borhane Annabi , Canadian Cancer Society , University Of Texas Md Anderson Cancer Center , Gettysburg Cancer Center , Consortium Qu , Drug Administration , Theratechnologies Inc , Department Of Investigational Cancer Therapeutics , Wall Street , Medical Director , Research Director , Gettysburg Cancer , Investigational Cancer Therapeutics , Cancer Center , Lead Principal Investigator , ஒன்றுபட்டது மாநிலங்களில் , சத்தீஷ் ஷா , டினா கைர் , கனடியன் புற்றுநோய் சமூகம் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் ம்ட் ஆண்டர்சன் புற்றுநோய் மையம் , கெடீஸ்பர்க் புற்றுநோய் மையம் , கூட்டமைப்பு கூ , சுவர் தெரு ,